Indication
Adenocarcinoma of the Stomach
1 clinical trial
1 product
3 drugs
Clinical trial
A Phase I and Randomized Phase II Double Blinded Placebo Controlled Study of mFOLFOX6 +/- AMG 337 in the First Line Treatment of Patients With Her2/Neu Negative and High MET Expressing Advanced Gastric and Esophageal AdenocarcinomaStatus: , Estimated PCD: 2015-03-06
Product
AMG 337Drug
oxaliplatinDrug
FOLFOXIRIDrug
fluorouracil